Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Neoplasm malignant
ADR ID BADD_A03005
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.01      Neoplasms malignant site unspecified NEC
16.16.01.001      Neoplasm malignant
Description New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. [MeSH]
MedDRA Code 10028997
MeSH ID D009369; D002277
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cancer | Cancer (NOS) | Carcinoma | Carcinoma NOS | Malignant neoplasm NOS | Malignant neoplasm of abdomen | Malignant neoplasm of lower limb | Malignant neoplasm of other and ill-defined sites | Malignant neoplasm of other specified sites | Malignant neoplasm of pelvis | Malignant neoplasm of upper limb | Malignant neoplasm without specification of site | Neoplasm malignant | Other malignant neoplasm of unspecified site | Transaminase cell carcinoma | Advanced cancer | Malignant tumor | Intra-abdominal cancer advanced | Malignant solid tumour | Malignant solid tumor | Malignant neoplasm growth accelerated | End stage cancer | Anaplastic carcinoma | Malignant tumour | Primary malignant neoplasm | Hormone sensitive malignant neoplasm | Blastoma | Neoplasms | Neoplasia | Neoplasias | Neoplasm | Tumors | Tumor | Cancers | Malignancy | Malignancies | Malignant Neoplasms | Malignant Neoplasm | Neoplasm, Malignant | Neoplasms, Malignant | Benign Neoplasms | Neoplasms, Benign | Benign Neoplasm | Neoplasm, Benign
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00701Dofetilide0.000254%
BADD_D00718Doxazosin--
BADD_D00723Doxorubicin--
BADD_D00730Dronedarone0.000980%
BADD_D00736Dutasteride0.000341%
BADD_D00749Efavirenz--
BADD_D00759Eltrombopag0.001692%
BADD_D00774Entecavir0.021247%
BADD_D00775Enzalutamide--
BADD_D00793Equilin sulfate--
BADD_D00800Erlotinib0.005876%
BADD_D00821Estradiol0.000092%
BADD_D00831Estrogens--
BADD_D00836Estropipate--
BADD_D00853Etophos--
BADD_D00856Etoricoxib--
BADD_D00857Etravirine0.019660%
BADD_D00858Everolimus0.005305%
BADD_D00861Exemestane0.015580%
BADD_D00864Ezetimibe0.000094%
BADD_D00869Famotidine0.000386%
BADD_D00879Fentanyl0.003700%
BADD_D00891Fesoterodine0.000992%
BADD_D00898Finasteride0.000157%
BADD_D00906Florbetapir--
BADD_D00912Fluconazole--
BADD_D00943Flutamide--
BADD_D00946Fluticasone furoate--
BADD_D00947Fluticasone propionate--
BADD_D00963Fosaprepitant dimeglumine--
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 10 Pages